{
    "nct_id": "NCT03411070",
    "official_title": "Using Radar Technology to Tag Abnormal Lymph Nodes for Removal During Surgery Following Neoadjuvant Chemotherapy",
    "inclusion_criteria": "* Able to give written informed consent to participate in the study\n* Patients with a breast cancer diagnosis of any subtype and a biopsy-proven positive axillary lymph node who will be treated first with chemotherapy\n* Enlarged lymph node and/or clip targetable with image guidance\n* Patients who are eligible for surgical resection of the primary breast cancer and targeted dissection of the axilla\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* More than 3 positive axillary nodes on imaging or matted nodes on clinical exam\n* Stage IV breast cancer\n* Pregnant or lactating females\n* Patients with inflammatory breast cancer\n* Patients with allergies to isosulfan blue or technetium, which would preclude sentinel node mapping\n* Patients who have had previous axillary surgery, including sentinel lymph node biopsy",
    "miscellaneous_criteria": ""
}